These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9221652)

  • 41. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Protective effect of the mushroom polysaccharide Schizophyllan against experimental bacterial infections].
    Komatsu N; Nagumo N; Okubo S; Koike K
    Jpn J Antibiot; 1973 Jun; 26(3):277-83. PubMed ID: 4270095
    [No Abstract]   [Full Text] [Related]  

  • 44. A group of bactericidal factors conserved by vertebrates for more than 300 million years.
    Kawakami M; Ihara I; Ihara S; Suzuki A; Fukui K
    J Immunol; 1984 May; 132(5):2578-81. PubMed ID: 6201550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The sensitivity of smooth and rough mutants of Salmonella typhimurium to bactericidal and bacteriolytic action of serum, lysozyme and to phagocytosis.
    Dlabac V
    Folia Microbiol (Praha); 1968; 13(5):439-49. PubMed ID: 4880678
    [No Abstract]   [Full Text] [Related]  

  • 46. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of cationic proteins from human granulocytes.
    Odeberg H; Olsson I
    J Clin Invest; 1975 Nov; 56(5):1118-24. PubMed ID: 241758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of protection against Salmonella infection in mice mediated by a synthetic lipopeptide analogue of bacterial lipoprotein in S. typhimurium vaccines.
    Schlecht S; Wiesmüller KH; Jung G; Bessler WG
    Zentralbl Bakteriol; 1989 Oct; 271(4):493-500. PubMed ID: 2684208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum opsonization of salmonella in sickle cell anemia.
    Hand WL; King NL
    Am J Med; 1978 Mar; 64(3):388-95. PubMed ID: 345801
    [No Abstract]   [Full Text] [Related]  

  • 51. Prolactin protection against lethal effects of Salmonella typhimurium.
    Di Carlo R; Meli R; Galdiero M; Nuzzo I; Bentivoglio C; Carratelli CR
    Life Sci; 1993; 53(12):981-9. PubMed ID: 8361329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative investigation of PMN leucocyte antimicrobial potential in animals of different species susceptibility to the plague agent.
    Isin ZhM; Suleimenov BM
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):307-12. PubMed ID: 2824603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Denatured bactericidal proteins: active per se, or reservoirs of active peptides?
    D'Alessio G
    FEBS Lett; 2011 Aug; 585(15):2403-4. PubMed ID: 21763313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of resistance to bacterial infections of mice with poly I-poly C.
    Weinstein MJ; Waitz JA; Came PE
    Nature; 1970 Apr; 226(5241):170. PubMed ID: 4908373
    [No Abstract]   [Full Text] [Related]  

  • 55. S. Typhimurium strategies to resist killing by cationic antimicrobial peptides.
    Matamouros S; Miller SI
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3021-5. PubMed ID: 25644871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural resistance of mice to Salmonella typhimurium: bactericidal activity and chemiluminescence response of murine peritoneal macrophages.
    Blumenstock E; Jann K
    J Gen Microbiol; 1981 Jul; 125(1):173-83. PubMed ID: 7038033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Protection of the mouse after oral vaccination by means of a orally administered killed pathogen strain of Salmonella typhimurium].
    Ivanoff B; Creach O; Fontanges R
    C R Seances Soc Biol Fil; 1974; 168(4-5):541-5. PubMed ID: 4281693
    [No Abstract]   [Full Text] [Related]  

  • 58. Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.
    Nishimura H; Gogami A; Miyagawa Y; Nanbo A; Murakami Y; Baba T; Nagasawa S
    Immunology; 2001 Aug; 103(4):519-25. PubMed ID: 11529944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning and expression in Escherichia coli and Staphylococcus aureus of the beta-lysin determinant from Staphylococcus aureus: evidence that bacteriophage conversion of beta-lysin activity is caused by insertional inactivation of the beta-lysin determinant.
    Coleman DC; Arbuthnott JP; Pomeroy HM; Birkbeck TH
    Microb Pathog; 1986 Dec; 1(6):549-64. PubMed ID: 3334158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunity to experimental salmonella infection and molecular-weight heterogeneity of antigenic complexes of S. typhimurium].
    Severtsova MK; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):79-85. PubMed ID: 324186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.